Histogen Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported total revenues of $5,000 against $108,000 a year ago. Loss from operations was $4,193,000 against $10,150,000 a year ago. Net loss was $3,720,000 against $10,178,000 a year ago. Net loss per share attributable to common stockholders was $0.10 against $1.52 a year ago. For the six months, the company reported total revenues of $436,000 against $1,086,000 a year ago. Loss from operations was $8,466,000 against $12,004,000 a year ago. Net loss was $7,998,000 against $12,012,000 a year ago. Net loss per share attributable to common stockholders was $0.23 against $2.39 a year ago.